Intellia Therapeutics NTLA
NASDAQ NTLA
$12.03 +0.61 (+5.34%)
At close: Sep 29, 2026 · 4:00 PM EDT

Intellia Therapeutics (NTLA) Enterprise Value (2016 - 2026)

Updated

Intellia Therapeutics (NTLA) posted Enterprise Value of $1.93 billion for Q2 2026, up 265.5% from $528.35 million a year earlier and up 65.3% from the prior quarter.

Analysis

Intellia Therapeutics (NTLA) Enterprise Value (2016 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Enterprise Value at Intellia Therapeutics was $594.43 million; for FY2025, it was $595.81 million, up 1.3% from FY2024.

  • Annual Enterprise Value shows a five-year compound annual growth rate of -27.7% (FY2020 to FY2025).
  • In prior years, Intellia Therapeutics' Enterprise Value was $588.15 million in FY2024 (-69.4%), $1.92 billion in FY2023 (+4.2%), $1.85 billion in FY2022 (-77.1%) and $8.06 billion in FY2021 (+168.0%).
  • The Q2 2026 figure stands as the highest quarterly Enterprise Value since Q3 2023.
  • On a year-over-year basis, Enterprise Value has increased in each of the last four quarters, with growth averaging 53.1% over the last eight quarters.
  • The strongest year-over-year quarter for Enterprise Value in the past five years was Q1 2026, with growth of 402.6%; the weakest was Q1 2025, with a decline of 87.5%.
  • According to Business Quant data, Enterprise Value for the three prior quarters was $1.17 billion (Q1 2026), $595.81 million (Q4 2025) and $1.49 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Intellia Therapeutics 1.60 Bn 1.60 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.93 Bn
Mar 31, 2026 1.17 Bn
Dec 31, 2025 595.81 Mn
Sep 30, 2025 1.49 Bn
Jun 30, 2025 528.35 Mn
Mar 31, 2025 232.42 Mn
Dec 31, 2024 588.15 Mn
Sep 30, 2024 1.43 Bn
Jun 30, 2024 1.51 Bn
Mar 31, 2024 1.86 Bn
Dec 31, 2023 1.92 Bn
Sep 30, 2023 1.96 Bn
Jun 30, 2023 2.69 Bn
Mar 31, 2023 2.35 Bn
Dec 31, 2022 1.85 Bn
Sep 30, 2022 3.46 Bn
Jun 30, 2022 3.06 Bn
Mar 31, 2022 4.64 Bn
Dec 31, 2021 8.06 Bn
Sep 30, 2021 9.17 Bn
API Access

Intellia Therapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=NTLA&period=max&api_key=YOUR_API_KEY